Tracing the evolution of polypharmacy and contraindicated drug‒drug interactions in people living with HIV in Belgium
BackgroundPeople living with HIV (PWH) are more likely to develop comorbid conditions, which increases the likelihood of polypharmacy and potentially harmful drug–drug interactions (DDIs). As antiretroviral (ARV) therapies evolve, the nature and frequency of these interactions also change, highlight...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Frontiers Media S.A.
2025-09-01
|
| Cyfres: | Frontiers in Pharmacology |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1632108/full |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
